CBPO [China Biologic Products] 8-K: China Biologic’s Board Has Appointed Two New Independent
[China Biologic’s Board Has Appointed Two New Independent Directors to Boost Corporate Governance BEIJING, China, April 25, 2012 /PRNewswire/ China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China, today announced that effective April 20, 2012, the Company’s Board of Directors (the “Board”) has appointed Mr.] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): April 20, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Taian City, Shandong, 271000 Peoples Republic of China 86-538 -620-2306 (Former name or former address, if changed since]